PI3Kγ Inhibition Alleviates Symptoms and Increases Axon Number in Experimental Autoimmune Encephalomyelitis Mice

Overview

Journal Neuroscience

Specialty Neurology

Date 2013 Sep 10

PMID 24012746

Citations 11

Authors

H Li

D Park

P M Abdul Muneer

P M Abdul-Muneer

B Xu

H Wang

B Xing

D Wu

S Li

Affiliations

Soon will be listed here.

Abstract

Phosphoinositide 3-kinase γ (PI3Kγ) is a shared downstream component of chemokine-mediated signaling pathways and regulates migration, proliferation and activation of inflammatory cells. PI3Kγ has been shown to play a crucial role in regulating inflammatory responses during the progression of several diseases. We investigated the potential function of PI3Kγ in mediating inflammatory reactions and the development of experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis (MS). We found that systemic treatment with selective PI3Kγ inhibitor AS-604850 significantly reduced the number of infiltrated leukocytes in the CNS and ameliorated the clinical symptoms of EAE mice. Treatment with this PI3Kγ inhibitor enhanced myelination and axon number in the spinal cord of EAE mice. Consistently, we demonstrated that PI3Kγ deletion in knockout mice mitigates the clinical sign of EAE compared to PI3Kγ+/+ controls. PI3Kγ deletion increased the number of axons in the lumbar spinal cord, including descending 5-HT-positive serotonergic fiber tracts. Our results indicate that PI3Kγ contributes to development of autoimmune CNS inflammation and that PI3Kγ blockade may provide a great potential for treating patients with MS.

Citing Articles

Development of PI3Kγ selective inhibitors: the strategies and application.

Gu D, Zhang M, Li J, Zhou Y, Sheng R Acta Pharmacol Sin. 2023; 45(2):238-247.

PMID: 37803138 PMC: 10789806. DOI: 10.1038/s41401-023-01166-8.

Inhibition of phosphoinositide‑3 kinases γ/δ ameliorates pulmonary granuloma by rescuing Treg function in a sarcoidosis model.

Zhang X, Dai Q, Shan J, Zhang S, Zhang B, Liu S Exp Ther Med. 2023; 25(5):225.

PMID: 37123205 PMC: 10133787. DOI: 10.3892/etm.2023.11923.

The role of PI3Kγ in the immune system: new insights and translational implications.

Lanahan S, Wymann M, Lucas C Nat Rev Immunol. 2022; 22(11):687-700.

PMID: 35322259 PMC: 9922156. DOI: 10.1038/s41577-022-00701-8.

Gene expression signatures of target tissues in type 1 diabetes, lupus erythematosus, multiple sclerosis, and rheumatoid arthritis.

Szymczak F, Colli M, Mamula M, Evans-Molina C, Eizirik D Sci Adv. 2021; 7(2).

PMID: 33523973 PMC: 7787485. DOI: 10.1126/sciadv.abd7600.

Sinomenine Alleviates Murine Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis through Inhibiting NLRP3 Inflammasome.

Kiasalari Z, Afshin-Majd S, Baluchnejadmojarad T, Azadi-Ahmadabadi E, Fakour M, Ghasemi-Tarie R J Mol Neurosci. 2020; 71(2):215-224.

PMID: 32812186 DOI: 10.1007/s12031-020-01637-1.

References

McGavern D, Murray P, Schmelzer J, Low P, Rodriguez M . Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis. Brain. 2000; 123 Pt 3:519-31. PMC: 5444460. DOI: 10.1093/brain/123.3.519. View

Chang J, Sukhova G, Libby P, Schvartz E, Lichtenstein A, Field S . Deletion of the phosphoinositide 3-kinase p110gamma gene attenuates murine atherosclerosis. Proc Natl Acad Sci U S A. 2007; 104(19):8077-82. PMC: 1864909. DOI: 10.1073/pnas.0702663104. View

Li S, Liu B, Budel S, Li M, Ji B, Walus L . Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury. J Neurosci. 2004; 24(46):10511-20. PMC: 6730300. DOI: 10.1523/JNEUROSCI.2828-04.2004. View

Lovett-Racke A, Trotter J, Lauber J, Perrin P, June C, Racke M . Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells. J Clin Invest. 1998; 101(4):725-30. PMC: 508618. DOI: 10.1172/JCI1528. View

Kobayashi N, Ueki K, Okazaki Y, Iwane A, Kubota N, Ohsugi M . Blockade of class IB phosphoinositide-3 kinase ameliorates obesity-induced inflammation and insulin resistance. Proc Natl Acad Sci U S A. 2011; 108(14):5753-8. PMC: 3078379. DOI: 10.1073/pnas.1016430108. View

Comerford I, Litchfield W, Kara E, McColl S . PI3Kγ drives priming and survival of autoreactive CD4(+) T cells during experimental autoimmune encephalomyelitis. PLoS One. 2012; 7(9):e45095. PMC: 3441529. DOI: 10.1371/journal.pone.0045095. View

Konrad S, Ali S, Wiege K, Syed S, Engling L, Piekorz R . Phosphoinositide 3-kinases gamma and delta, linkers of coordinate C5a receptor-Fcgamma receptor activation and immune complex-induced inflammation. J Biol Chem. 2008; 283(48):33296-303. PMC: 2662258. DOI: 10.1074/jbc.M804617200. View

Martino G, Hartung H . Immunopathogenesis of multiple sclerosis: the role of T cells. Curr Opin Neurol. 1999; 12(3):309-21. DOI: 10.1097/00019052-199906000-00010. View

Mi S, Hu B, Hahm K, Luo Y, Hui E, Yuan Q . LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat Med. 2007; 13(10):1228-33. DOI: 10.1038/nm1664. View

10.

Ward S . Do phosphoinositide 3-kinases direct lymphocyte navigation?. Trends Immunol. 2004; 25(2):67-74. DOI: 10.1016/j.it.2003.12.003. View

11.

Berod L, Heinemann C, Heink S, Escher A, Stadelmann C, Drube S . PI3Kγ deficiency delays the onset of experimental autoimmune encephalomyelitis and ameliorates its clinical outcome. Eur J Immunol. 2011; 41(3):833-44. DOI: 10.1002/eji.201040504. View

12.

Hirsch E, Katanaev V, Garlanda C, Azzolino O, Pirola L, Silengo L . Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science. 2000; 287(5455):1049-53. DOI: 10.1126/science.287.5455.1049. View

13.

Dill J, Wang H, Zhou F, Li S . Inactivation of glycogen synthase kinase 3 promotes axonal growth and recovery in the CNS. J Neurosci. 2008; 28(36):8914-28. PMC: 6670875. DOI: 10.1523/JNEUROSCI.1178-08.2008. View

14.

Medina-Tato D, Ward S, Watson M . Phosphoinositide 3-kinase signalling in lung disease: leucocytes and beyond. Immunology. 2007; 121(4):448-61. PMC: 2265972. DOI: 10.1111/j.1365-2567.2007.02663.x. View

15.

Laffargue M, Calvez R, Finan P, Trifilieff A, Barbier M, Altruda F . Phosphoinositide 3-kinase gamma is an essential amplifier of mast cell function. Immunity. 2002; 16(3):441-51. DOI: 10.1016/s1074-7613(02)00282-0. View

16.

Li Z, Jiang H, Xie W, Zhang Z, Smrcka A, Wu D . Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction. Science. 2000; 287(5455):1046-9. DOI: 10.1126/science.287.5455.1046. View

17.

Hayer S, Pundt N, Peters M, Wunrau C, Kuhnel I, Neugebauer K . PI3Kgamma regulates cartilage damage in chronic inflammatory arthritis. FASEB J. 2009; 23(12):4288-98. DOI: 10.1096/fj.09-135160. View

18.

Barber D, Bartolome A, Hernandez C, Flores J, Redondo C, Fernandez-Arias C . PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus. Nat Med. 2005; 11(9):933-5. DOI: 10.1038/nm1291. View

19.

Hauser S, Oksenberg J . The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron. 2006; 52(1):61-76. DOI: 10.1016/j.neuron.2006.09.011. View

20.

Del Prete A, Vermi W, Dander E, Otero K, Barberis L, Luini W . Defective dendritic cell migration and activation of adaptive immunity in PI3Kgamma-deficient mice. EMBO J. 2004; 23(17):3505-15. PMC: 516633. DOI: 10.1038/sj.emboj.7600361. View